A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease
Conditions
- Non Clear Cell Renal Cell Carcinoma (nccRCC)
Interventions
- DRUG: lenvatinib
- DRUG: everolimus
Sponsor
Eisai Inc.
Collaborators